Eagle Health Investments LP Q3 2025 Filing

Filed November 7, 2025

Portfolio Value

$380.9B

Holdings

23

Report Date

Q3 2025

Filing Type

13F-HR

All Holdings (23 positions)

#StockSharesValue% PortfolioType
1
ARGXARGENX SE
77,430$57.1B14.99%
2
IM8NINSMED INC
271,600$39.1B10.27%
3
NTRANATERA INC
203,664$32.8B8.61%
4
ICLRICON PLC
182,590$32.0B8.39%
5
ILMNILLUMINA INC
322,261$30.6B8.03%
6
NBIXNEUROCRINE BIOSCIENCES INC
162,800$22.9B6.00%
7
RAREULTRAGENYX PHARMACEUTICAL IN
697,000$21.0B5.50%
8
BMRNBIOMARIN PHARMACEUTICAL INC
366,812$19.9B5.22%
9
GHGUARDANT HEALTH INC
284,100$17.8B4.66%
10
EXASEXACT SCIENCES CORP
270,950$14.8B3.89%
11
SRRKSCHOLAR ROCK HLDG CORP
363,300$13.5B3.55%
12
BBIOBRIDGEBIO PHARMA INC
259,300$13.5B3.54%
13
PRCTPROCEPT BIOROBOTICS CORP
308,434$11.0B2.89%
14
ALNYALNYLAM PHARMACEUTICALS INC
23,686$10.8B2.84%
15
AKROAKERO THERAPEUTICS INC
226,400$10.7B2.82%
16
AGIOAGIOS PHARMACEUTICALS INC
246,230$9.9B2.59%
17
FTREFORTREA HLDGS INC
988,772$8.3B2.19%
18
CMPSCOMPASS PATHWAYS PLC
935,450$5.4B1.41%
19
CNTACENTESSA PHARMACEUTICALS PLC
103,100$2.5B0.66%
20
ALKSALKERMES PLC
81,800$2.5B0.64%
21
ISRGINTUITIVE SURGICAL INC
4,390$2.0B0.52%
22
IMCRIMMUNOCORE HLDGS PLC
46,300$1.7B0.44%
23
VIRVIR BIOTECHNOLOGY INC
240,500$1.4B0.36%